SCHEMBL1708445

SCHEMBL1708445

Cc1nc(OC(F)F)nc(C)c1-c1cccc(CNc2ccc3c(c2)OC[C@H]3CC(=O)[O-])c1C.Cc1nc(OC(F)F)nc(C)c1-c1cccc(CNc2ccc3c(c2)OC[C@H]3CC(=O)[O-])c1C.[Ca+2]

nearest known ligand 0.38

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 19/20 0.38
PPARD Q03181 6/20 0.34
PPARG P37231 1/20 0.32
PDCD1 Q15116 1/20 0.32
CD274 Q9NZQ7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10291778 0.92 FFAR1 (0.39) FFAR1PPARDPDCD1CD274
SCHEMBL1707920 0.92 FFAR1 (0.46) FFAR1PPARDPPARG
SCHEMBL1707921 0.85 CD274 (0.34) FFAR1PDCD1CD274
SCHEMBL1708447 0.84 CD274 (0.33) FFAR1PDCD1CD274
SCHEMBL1708437 0.77 PDCD1 (0.33) PDCD1CD274
SCHEMBL1708103 0.76 FFAR1 (0.39) FFAR1PPARDPPARGPDCD1CD274
SCHEMBL1708294 0.75 FFAR1 (0.45) FFAR1PPARDPPARG
SCHEMBL1708346 0.75 FFAR1 (0.43) FFAR1PPARDPPARG
SCHEMBL10291219 0.73 FFAR1 (0.40) FFAR1PPARDPPARGPDCD1CD274
SCHEMBL1708612 0.73 SMN1; SMN2 (0.38) FFAR1PPARDPPARGPDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440541-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2012-04-18 EP disclosed
WO-2010143733-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-16 WO disclosed